Remolina-Schlig M

Idioma: Español
Referencias bibliográficas: 21
Paginas: 189-190
Archivo PDF: 42.70 Kb.

RESUMEN

La procalcitonina (PC) es un marcador útil para apoyar el diagnóstico de infecciones graves. Así como en otros estados en que ocurre inflamación sistémica, la PC en suero aumenta acorde con la intensidad de la reacción del cuerpo. En trauma grave, pancreatitis aguda o infecciones localizadas, la elevación de la PC no llega a los niveles de aquéllos con infecciones graves producidas por bacterias, hongos o protozoarios. Por lo contrario en las infecciones virales graves no ocurre un aumento significativo de PC, permitiendo esto apoyar el diagnóstico diferencial. Durante el tratamiento antibiótico la PC permite vigilar la respuesta al tratamiento para descontinuar o modificar el esquema según los niveles de esta prohormona. A diferencia de la proteína C reactiva que se eleva indistintamente, la PC refleja en forma más cercana la respuesta del cuerpo a las infecciones graves y en casos de inflamación grave sin infección hacer el diagnóstico diferencial como en pancreatitis con o sin infección agregada.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993: 341: 515-518.

2. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-1608.

3. Brunkhorst FM. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 24: 888-889.

4. Gramm H-J, Dollinger P, Beier W. Procalcitonin-A new marker of host inflammatory response. Longitudinal studies in patients with sepsis and peritonitis. Chir Gastroenterol 1995; 11 (Suppl 2): 51-54.

5. Bertagna XY, Nicholson WE, Pettengill OS, Sorensen GD , Mount ChD, Orth DN. Ectopic production of high molecular weight calcitonin and corticotropin by human small cell carcinoma cells in tissue culture: evidence for separate precursors. J Clin Endocrinol Metab 1978; 47: 1390-1393.

6. Chiesa C, Panero A, Rossi N, Stegagno M, De Giusti M, Osborn JF, Pacifico L. Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates. Clin Infect Dis 1998: 26: 664-672.

7. Meisner M, Tschaikowsky K, Hutzler A, Schick C, Schuttler J. Postoperative plasma concentrations of procalcitonin after different types of surgery. Intensive Care Med 1998: 24: 680-684.

8. Mimoz O, Benoist JF, Edouard AR, Assicot M, Bohuon C, Samii K. Procalcitonin and C-reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med 1998: 24: 185-188.

9. Rau B, Steinbach G , Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997: 41: 832-840.

10. Brunkhorst FM, Forycki ZF, Wagner J. Discrimination of infectious and non-infectious aetiologies of the adult respiratory distress syndrome (ARDS) with procalcitonin immunoreactivity. Clin Intensive Care 1995; 6: 3.

11. Eberhard OK, Langefeld I, Kuse ER, Brunkhorst FM, Kliem V, Schlitt HJ, Pichlmayr R, Koch KM, Brunkhorst R. Procalcitonin in the early phase after renal transplantation-will it add to diagnostic accuracy? Clin Transplant 1998: 12: 206-211.

12. Smith MD, Suputtamongkol Y, Chaowagul W, Assicot M, Bohuon C, Petitjean S, White NJ. Elevated serum procalcitonin levels in patients with melioidosis. Clin Infect Dis 1995; 20: 641-645.

13. Schröder J, Staubach KH, Zabel P, Stüber F, Kremer B. Procalcitonin as a marker of severity in septic shock. Langenbeck’s Arch Surg 1999: 384: 33-38.

14. De Werra I, Jaccard C, Corradin SB, Chiolero R, Yersin B, Gallati H, Assicot M, Bohuon C, Baumgartner J-D, Glauser MP, Heumann D. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997: 25: 607-613.

15. Smith RP, Lipworth BJ. C-reactive protein in simple community acquired pneumonia. Chest 1995; 107: 1028-1031.

16. Monneret G, Labaune JM, Isaac C, Bienvenu F, Putet G, Bienvenu J. Procalcitonin and C-reactive protein levels in neonatal infections. Acta Paediatr 1997; 86: 209-212.

17. Nylen ES, Whang KT, Snider RHJ, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001-1006.

18. Gendrel D, Raymond J, Assicot M, Moulin F, Iniguez JL, Lebon P, Bohuon C. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-1242.

19. Oberhoffer M, Bitterlich A, Hentschel T, Meier-Hellmann A, Vogelsang H, Reinhart K. Procalcitonin (ProCt) correlates better with the ACCP/SCCM consensus conference definitions than other specific markers of the inflammatory response. Clin Intensive Care 1996;7: 46.

20. Yentis SM, Soni N, Sheldon J. C-reactive protein as an indicator of resolution of sepsis in the intensive care unit. Intensive Care Med 1995: 21: 602-605.

21. Balc C, Sungurtekin H, Gürses E, Sungurtekin U, Kaptanoglu B. Usefulness of procalcitonin for diagnosis of sepsis in the intensive care unit. Crit Care 2003; 7(1): 85-90.